Loading publications…
The last 5 uploaded publications
Human-correlated genetic models identify precision therapy for liver cancer
Miryam Müller, Stephanie May, H. G. HALL, Timothy J. Kendall, Lynn McGarry, Lauriane Blukacz, Sandro Nuciforo, Αναστασία Γεωργακοπούλου, Thomas Jamieson, Narisa Phinichkusolchit, Sandeep Dhayade, Toshiyasu Suzuki, Júlia Huguet‐Pradell, Ian R. Powley, Leah Officer-Jones, Rachel Pennie, Roger Esteban-Fabró, Albert Gris‐Oliver, Roser Pinyol, George Skalka, Jack Leslie, Matthew Hoare, Joep Sprangers, Gaurav Malviya, Agata Mackintosh, Emma Johnson, Misti McCain, John Halpin, Christos Kiourtis, Colin Nixon, Graeme M. Clark, William R. Clark, Robin Shaw, Ann Hedley, Thomas M. Drake, Ee Hong Tan, Matt Neilson, Daniel J. Murphy, David Y. Lewis, Helen L. Reeves, John Le Quesne, Derek A. Mann, Leo M. Carlin, Karen Blyth, Josep M. Llovet, Markus H. Heim, Owen J. Sansom, Crispin Miller, Thomas G. Bird (2025). Human-correlated genetic models identify precision therapy for liver cancer. Nature, DOI: 10.1038/s41586-025-08585-z.
Article145 days agoTHU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma
Agavni Mesropian, Albert Gris‐Oliver, Ugne Balaseviciute, Martí Torres-Marcen, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, David Camell, Judit Peix, Elisa Fernández-Martínez, Júlia Huguet‐Pradell, Ieva Keraite, Roger Esteban-Fabró, Takayuki Kimura, Alka A. Potdar, Marina Bárcena‐Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan N. Thung, Daniela Sia, Roser Pinyol, Josep M. Llovet (2025). THU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma. Journal of Hepatology, 82, pp. S431-S432, DOI: 10.1016/s0168-8278(25)01237-1.
Article145 days agoSAT-113 The intratumoral microbiome in HCC and its impact on treatment response
Ugne Balaseviciute, Mohammad Rahbari, Fabian Springer, Roser Pinyol, Roger Esteban-Fabró, Albert Gris‐Oliver, Marta Piqué‐Gili, Agavni Mesropian, Jessica Zucman‐Rossi, Jeanin E. van Hooft, Josep M. Llovet, Mathias Heikenwälder (2025). SAT-113 The intratumoral microbiome in HCC and its impact on treatment response. Journal of Hepatology, 82, pp. S463-S463, DOI: 10.1016/s0168-8278(25)01307-8.
Article145 days agoTOP-128-YI Efficacy of WNTinib, a novel selective therapeutic for CTNNB1mutant tumors, in preclinical models of hepatoblastoma
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Elisa Fernández-Martínez, Albert Gris‐Oliver, Roser Pinyol, Alex Rialdi, Agavni Mesropian, Gulay Ulukaya, Dan Hasson, Ieva Keraite, Swan N. Thung, Ernesto Guccione, Josep M. Llovet (2025). TOP-128-YI Efficacy of WNTinib, a novel selective therapeutic for CTNNB1mutant tumors, in preclinical models of hepatoblastoma. Journal of Hepatology, 82, pp. S429-S429, DOI: 10.1016/s0168-8278(25)01230-9.
Article145 days agoTHU-078 Artificial intelligence-driven prediction of biology-related poor outcome and presence of vascular invasion in hepatocellular carcinoma
Agavni Mesropian, Tobias Paul Seraphin, Laura Žigutyteè, James Brooks, Ezequiel Mauro, Albert Gris‐Oliver, Roser Pinyol, Carla Montironi, Marko van Treeck, Jakob Nikolas Kather, Tom Luedde, Josep M. Llovet (2025). THU-078 Artificial intelligence-driven prediction of biology-related poor outcome and presence of vascular invasion in hepatocellular carcinoma. Journal of Hepatology, 82, pp. S432-S432, DOI: 10.1016/s0168-8278(25)01238-3.
Article145 days ago